From Incidence to Inequality: Charting the Global Burden of Testicular Cancer in Adolescents and Young Adults for the Global Burden of Disease Study 2021
Xie, H.; Sun, Q.; Xue, P.; Chu, X.; Chu, F.; Zhu, S.; Xi, L.; Hong, J.; Lin, X.; Lyu, J.; Wang, N.
Show abstract
BackgroundThe incidence of testicular cancer (TC) among adolescents and young adults (AYAs: aged 15-39 years) population presents unique biological and epidemiologic characteristics, and there is currently a wide variation in incidence and survival across regions. MethodsThe data on incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) owing to TC were obtained from the Global Burden of Disease 2021. We quantified differences in the burden of TC among AYA at the socio-demographic index (SDI), regional, and national levels. Decomposition analysis was used to identify the main drivers of variation in the burden. Frontier analysis demonstrated the potential for countries to reduce the burden. ResultsGlobally, there were 28499 new cases, 61596 prevalent cases, 5699 mortality cases, and 376564 DALYs due to TC among AYA in 2021. Between 1990 and 2021, the age-standardized incidence rate (ASIR) and age-standardized prevalence rate (ASPR) increased while the age-standardized mortality rate (ASMR) and age-standardized DALYs rate (ASDR) decreased. Regionally, Southern Latin America exhibited the highest ASRs. Nationally, Monaco ranked highest in ASIR and ASPR, while Mexico had the highest ASMR and ASDR. Population growth and epidemiological changes were major drivers for the burden of DALYs in middle SDI regions, which had the greatest potential for improvement. ConclusionsThe global burden of TC among AYA has risen, which is most pronounced in middle SDI regions. Among the AYA population, TC survivors have increased significantly due to the decreased ASMR and ASDR, who badly need more attention for TC treatment.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Comprehensive analysis of prostate cancer life expectancy, loss of life expectancy, and healthcare expenditures: Taiwan national cohort study spanning 2008 to 2019 94%
- Glyoxalase 1: emerging biomarker and therapeutic target in cervical cancer progression 92%
- Childhood Cancer Survival in the Highly Vulnerable Population of South Texas: A Cohort Study 92%
Similar papers in this journal
- Changes in the prevalence of the common risk factors for non-communicable diseases in Uganda between 2014 and 2023: Informed by nationally representative cross-sectional surveys 92%
- Knowledge, perception, and attitude toward premarital screening among university students in Kurdistan region- Iraq 91%
- Uptake and factors associated with cervical cancer screening among women aged 18-49 years at a public hospital in Coastal Kenya 91%
Similar papers in this journal
- SARS-CoV-2 Seroprevalence and Risk Factors among Convalescents in Sichuan Province, China: a retrospective cohort study 92%
- Covid-19 Incidence And Mortality By Age Strata And Comorbidities In Mexico City: A Focus In The Pediatric Population 91%
- Projecting trends in the disease burden of adult edentulism in China between 2020 and 2030: a systematic study based on the global burden of disease 91%
Similar papers in this journal
- Micronutrient deficiencies and the double burden of malnutrition in Vietnamese female adolescents: a national cross-sectional study in 2020 90%
- Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: a hospital-based retrospective cohort study 89%
- Clustering Lifestyle Risk Behaviors among Vietnamese Adolescents and Roles of School: A Bayesian Multilevel Analysis of Global School-Based Student Health Survey 2019 89%
Similar papers in this journal
- Risk factors associated with mortality of COVID-19 in 3125 counties of the United States 91%
- The relative transmissibility of shigellosis among male and female individuals in Hubei Province, China: a modelling study 90%
- Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine in High-Risk Occupational Population: a randomized, parallel, controlled clinical trial 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.